ALLO logo

Allogene Therapeutics, Inc. (ALLO)

Profile

Full Name

Allogene Therapeutics, Inc.

Ticker

NASDAQ: ALLO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 11, 2018

Indexes

Not included

Website

http://allogene.com

Employees

226

Key Details

Price

$1.50(-0.66%)

Market cap

$328.10M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$22.00K(-76.84% YoY)

Annual EPS

-$1.32(+36.84% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.50
    ALLO price is $1.50

    30-Day Relative Volume

    0.87
    ALLO 30-day relative volume is 0.87

    Price Performance

    Price Most recent change

    -0.66%
    ALLO price was down -0.66% on Jul 25, 2025

    Price YTD change

    -29.58%
    ALLO price is down -29.58% since January 1st

    Price 1-year change

    -48.45%
    ALLO price is down -48.45% year-on-year

    Price 3-year change

    -88.99%
    ALLO price is down -88.99% over the past 3 years

    Price Range

    Price All-time high

    $55.00
    ALLO price is currently -97.27% below its historical high of $55.00

    Price 3-year low

    $0.86
    ALLO price is currently +74.42% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $328.10M
    ALLO market capitalization is $328.10 million

    Market cap 3-year change

    -83.24%
    ALLO market capitalization is down -83.24% over the past 3 years

    Market cap All-time high

    $6.77B
    ALLO market capitalization is currently -95.16% below its historical high of $6.77 billion

    Market cap sector rank

    59.19%
    ALLO market capitalization is higher than 59.19% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.63%
    ALLO shares outstanding is up +4.63% year-on-year

    Shares Outstanding 3-Year Change

    +52.19%
    ALLO shares outstanding is up +52.19% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.19
    ALLO beta is 1.19

    200-day SMA

    $1.83
    ALLO price is currently -18.07% below its 200-day simple moving average

    50-day SMA

    $1.25
    ALLO price is currently +19.69% above its 50-day simple moving average

    RSI

    62.32
    ALLO 14-day relative strength index is 62.32

    Volume

    0.87
    ALLO 30-day relative volume is 0.87

    ATR

    $0.11
    ALLO average true range is $0.11

    10-day Historical Volatility

    111.18%
    ALLO 10-day historical volatility is 111.18%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $22.00K
    ALLO annual revenue is $22.00 thousand

    Revenue Analysts estimate

    $7690.00
    ALLO annual revenue is currently +186.09% higher than the consensus analysts' forecast

    Revenue 1-year change

    -76.84%
    ALLO annual revenue is down -76.84% year-on-year

    Revenue Sector rank

    3.09%
    ALLO annual revenue is higher than 3.09% of companies in Healthcare sector

    EPS

    EPS

    -$1.32
    ALLO annual earnings per share is -$1.32

    EPS Analysts estimate

    -$1.01
    ALLO annual earnings per share is currently +30.69% higher than the consensus analysts' forecast

    EPS 1-year change

    +36.84%
    ALLO annual earnings per share is up +36.84% year-on-year

    EPS Sector rank

    48.63%
    ALLO annual earnings per share is higher than 48.63% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ALLO annual gross profit value is unknown

    Gross margin

    -
    ALLO annual gross profit margin value is unknown

    Operating profit

    -$257.48M
    ALLO annual operating income is -$257.48 million

    Operating margin

    -1.17M%
    ALLO annual operating profit margin is -1.17 million%

    Net income

    -$257.59M
    ALLO annual net profit is -$257.59 million

    Net margin

    -1.17M%
    ALLO annual net profit margin is -1.17 million%

    Expenses

    Total expenses

    $257.50M
    ALLO annual total expenses is $257.50 million

    Operating expenses

    $257.50M
    ALLO annual total operating expenses is $257.50 million

    Cost of goods sold

    -
    ALLO annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $65.20M
    ALLO annual SGA is $65.20 million

    Depreciation and amortization

    $13.64M
    ALLO annual depreciation & amortization is $13.64 million

    Interest expense

    $181.00K
    ALLO annual interest expense is $181.00 thousand

    Income tax

    $443.00K
    ALLO annual income tax is $443.00 thousand

    EBIT & EBITDA

    EBIT

    -$256.97M
    ALLO annual earnings before interest & taxes is -$256.97 million

    EBITDA

    -$243.33M
    ALLO annual EBITDA is -$243.33 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $548.71M
    ALLO annual total assets is $548.71 million

    Non current assets

    $245.32M
    ALLO annual long term assets is $245.32 million

    Current assets

    $303.39M
    ALLO annual total current assets is $303.39 million

    Cash and cash equivalents

    $75.22M
    ALLO annual cash & cash equivalents is $75.22 million

    Accounts receivable

    -
    ALLO annual accounts receivable value is unknown

    Inventory

    -
    ALLO annual inventory value is unknown

    Liabilities

    Total liabilities

    $126.53M
    ALLO annual total liabilities is $126.53 million

    Long term liabilities

    $91.01M
    ALLO annual total long term liabilities is $91.01 million

    Current liabilities

    $35.52M
    ALLO annual total current liabilities is $35.52 million

    Accounts payable

    $5.39M
    ALLO annual accounts payable is $5.39 million

    Debt

    Total debt

    $90.76M
    ALLO annual total debt is $90.76 million

    Total debt 1-year change

    -4.59%
    ALLO annual total debt is down -4.59% year-on-year

    Long term debt

    $83.25M
    ALLO annual long term debt is $83.25 million

    Short term debt

    $7.51M
    ALLO annual short term debt is $7.51 million

    Equity & Capital

    Shareholders equity

    $422.18M
    ALLO annual stockholders equity is $422.18 million

    Book value

    $422.18M
    ALLO annual book value is $422.18 million

    Retained earnings

    -$1.82B
    ALLO annual retained earnings is -$1.82 billion

    Working capital

    $267.86M
    ALLO annual working capital is $267.86 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$200.30M
    ALLO annual cash flow from operations is -$200.30 million

    Cash from operations 1-year change

    +15.75%
    ALLO annual cash flow from operations is up +15.75% year-on-year

    Cash from investing

    $75.69M
    ALLO annual cash flow from investing activities is $75.69 million

    Cash from investing 1-year change

    -53.65%
    ALLO annual cash flow from investing activities is down -53.65% year-on-year

    Cash from financing

    $116.67M
    ALLO annual cash flow from financing activities is $116.67 million

    Cash from financing 1-year change

    +21.92%
    ALLO annual cash flow from financing activities is up +21.92% year-on-year

    CAPEX

    CAPEX

    $694.00K
    ALLO annual capital expenditures is $694.00 thousand

    CAPEX 1-year change

    -54.22%
    ALLO annual capital expenditures is down -54.22% year-on-year

    Free Cash Flow

    Free cash flow

    -$200.99M
    ALLO annual free cash flow is -$200.99 million

    Free cash flow 1-year change

    +15.99%
    ALLO annual free cash flow is up +15.99% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ALLO annual gross profit margin value is unknown

    Operating margin

    -1.17M%
    ALLO annual operating profit margin is -1.17 million%

    Net margin

    -1.17M%
    ALLO annual net profit margin is -1.17 million%

    ROA & ROE

    ROA

    -43.24%
    ALLO annual return on assets is -43.24%

    ROE

    -55.13%
    ALLO annual return on equity is -55.13%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ALLO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ALLO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.85
    ALLO price to book ratio is 0.85

    PB ratio Sector rank

    34.41%
    ALLO price to book ratio is higher than 34.41% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ALLO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ALLO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $366.93M
    ALLO enterprise value is $366.93 million

    Enterprise value Sector rank

    61.47%
    ALLO enterprise value is higher than 61.47% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.54
    ALLO EV/EBITDA is -1.54

    EV/EBITDA Sector rank

    43.75%
    ALLO EV/EBITDA is higher than 43.75% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.54
    ALLO annual current ratio is 8.54

    Quick ratio

    -
    ALLO annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ALLO annual debt to equity ratio is 0.00

    Interest coverage ratio

    -1419.70
    ALLO annual interest coverage ratio is -1419.70

    Risk & Stability

    Piotroski F-Score

    -
    ALLO piotroski f-score value is unknown

    Altman Z-Score

    -4.05
    ALLO altman z-score is -4.05

    Analyst ratings

    Recent major analysts updates

    May 15, 25 Citigroup
    Buy
    May 14, 25 Truist Securities
    Buy
    May 14, 25 RBC Capital
    Outperform
    May 14, 25 Piper Sandler
    Overweight
    May 14, 25 Oppenheimer
    Outperform
    May 14, 25 Baird
    Outperform
    Mar 19, 25 HC Wainwright & Co.
    Buy
    Mar 14, 25 RBC Capital
    Outperform
    Mar 14, 25 Citizens Capital Markets
    Market Outperform
    Mar 14, 25 Canaccord Genuity
    Buy

    Institutional Ownership

    Screeners with ALLO included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Allogene Therapeutics, Inc.?
    • Does Allogene Therapeutics, Inc. pay dividends?
    • What sector is Allogene Therapeutics, Inc. in?
    • What industry is Allogene Therapeutics, Inc. in?
    • What country is Allogene Therapeutics, Inc. based in?
    • When did Allogene Therapeutics, Inc. go public?
    • Is Allogene Therapeutics, Inc. in the S&P 500?
    • Is Allogene Therapeutics, Inc. in the NASDAQ 100?
    • Is Allogene Therapeutics, Inc. in the Dow Jones?
    • When was Allogene Therapeutics, Inc.'s last earnings report?
    • When does Allogene Therapeutics, Inc. report earnings?

    What is the ticker symbol for Allogene Therapeutics, Inc.?

    The ticker symbol for Allogene Therapeutics, Inc. is NASDAQ:ALLO

    Does Allogene Therapeutics, Inc. pay dividends?

    No, Allogene Therapeutics, Inc. does not pay dividends

    What sector is Allogene Therapeutics, Inc. in?

    Allogene Therapeutics, Inc. is in the Healthcare sector

    What industry is Allogene Therapeutics, Inc. in?

    Allogene Therapeutics, Inc. is in the Biotechnology industry

    What country is Allogene Therapeutics, Inc. based in?

    Allogene Therapeutics, Inc. is headquartered in United States

    When did Allogene Therapeutics, Inc. go public?

    Allogene Therapeutics, Inc.'s initial public offering (IPO) was on October 11, 2018

    Is Allogene Therapeutics, Inc. in the S&P 500?

    No, Allogene Therapeutics, Inc. is not included in the S&P 500 index

    Is Allogene Therapeutics, Inc. in the NASDAQ 100?

    No, Allogene Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Allogene Therapeutics, Inc. in the Dow Jones?

    No, Allogene Therapeutics, Inc. is not included in the Dow Jones index

    When was Allogene Therapeutics, Inc.'s last earnings report?

    Allogene Therapeutics, Inc.'s most recent earnings report was on May 13, 2025

    When does Allogene Therapeutics, Inc. report earnings?

    The next expected earnings date for Allogene Therapeutics, Inc. is August 7, 2025
    On this page